Faculty

Burcu Darst

Affiliate Assistant Professor, Epidemiology

206-667-1036

Education

PhD Epidemiology, University of Wisconsin (Madison), 2018
BS Cognitive Science, University of California (San Diego), 2009

Contact

206-667-1036

Office M4-B873
1100 Fairview Ave N
Seattle, WA 98109
View Website »

Bio

Dr. Burcu Darst’s is a genetic epidemiologist with research focused on identifying and understanding genetic and multi-omic risk factors of complex diseases in diverse populations, particularly how they relate to health disparities. Her research lies predominantly in studying prostate cancer, type 2 diabetes, and Alzheimer’s disease, with the underlying goal of identifying risk factors that could prevent the onset and health disparities of these diseases. Dr. Darst’s research is based on a variety of approaches, including using rare genetic variants captured with genomic sequencing, genome-wide association studies, polygenic risk scores, and metabolomics to understand disease risk. Currently, she is leading an effort to improve understanding of the genomic and metabolic mechanisms contributing to prostate cancer risk in men from diverse populations as well as improving the utility of polygenic risk scores and rare genetic variants for the prediction of prostate cancer across multi-ancestry patient populations.This research is conducted in collaboration with large-scale international collaborations investigating genetic risk of prostate cancer.

Research Interests

Prostate cancer prevention, Health disparities, Genetic risk factors, Molecular biomarkers, Multi-omic integration

Recent Publications (PubMed)

Racial and ethnic differences in the impact of air pollution on the risk of Alzheimer's disease and related dementias in the Multiethnic Cohort Study.
(2026 Feb 24)
Environ Int 209(): 110169
Wu AH, Wu J, Tseng C, Darst BF, Park SY, Stram DO, Larson T, Fruin S, Setiawan VW, Yu X, Wilkens LR, Hu H, Haiman C, Ritz B, Crimmins EM, Lim U, Cheng I, Marchand LL

Validation and context-dependent effects of a prostate cancer polygenic risk score in the All of Us Research Program.
(2026 Feb 5)
Am J Hum Genet 113(2): 392-398
Cheng S, Suger AH, Goss LB, Zhang J, Fuller H, Guo B, Lindström S, Darst BF

Pre-diagnostic circulating untargeted metabolomics and risk of overall and clinically significant prostate cancer: a systematic review and meta-analysis.
(2026 Jan 10)
Br J Cancer
Fuller H, Agasaro OP, Guevara JM, Darst BF

Recommendations for responsible use of population descriptors in polygenic risk score development.
(2025 Dec)
Nat Genet 57(12): 2962-2971
Smith JL, Adebamowo CA, Adebamowo SN, Darst BF, Fullerton SM, Gogarten SM, Hamed ME, Hirbo JB, Hysong MR, Johar AS, Khan AT, Kullo IJ, Konigsberg IR, Kraft P, Lange LA, Li Y, Martin AR, Nelson SC, Choudhury A, Ramsay M, Cobran EK, Schaid DJ, Sharma J, Wang Y, Wojcik GL, Polygenic Risk Methods Development (PRIMED) Consortium, Sun Q

Validation and context-dependent effects of a prostate cancer polygenic risk score in the All of Us Research Program.
(2025 Oct 3)
medRxiv
Cheng S, Suger AH, Goss LB, Zhang J, Fuller H, Guo B, Lindström S, Darst BF

Show complete publication list

In the News

No news articles at this time.